PATENT CLAIM ANALYSIS

Application Number: 16013834
Application Type: Utility
Filing Date: 2018-06
Publication Date: 2018-10
Patent Classification: ["424", "130100"]

Abstract:
The present invention provides methods for improving the efficacy of a vaccine in the treatment of cancer. The methods of the invention comprise the administration of at least two doses of an agent that interferes with DNA replication prior to vaccination with a survivin vaccine. Also provided are compositions for use in the methods of the invention.

Claim (Index 13):
The method according to  claim 12 , wherein the metronomic regimen comprises administering the agent to the subject daily for a period of about one week every second week.

Metadata:
- Claim Count in Document: 98.0
- Percentile: 94.0
- Lexical Diversity: 1.57895
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['10580016', '10543755', '15568967', '15231075', '14991807']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7737082956573021
- 35 USC 102 Novelty (BERT): 0.5264635760543952
- Combined Prediction Score: 0.7489838236970116
- Mean Citation Score: 316.253826
- Max Citation Score: 332.10287
- Similarity Product: 208.5802062526548

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test